Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Sandra Bodeau"'
Autor:
Pauline Caillard, Youssef Bennis, Cédric Boudot, Denis Chatelain, Pierre Rybarczyk, Agnès Boullier, Sabrina Poirot, Dimitri Titeca-Beauport, Sandra Bodeau, Gabriel Choukroun, Saïd Kamel, Isabelle Six, Julien Maizel
Publikováno v:
Renal Failure, Vol 46, Iss 2 (2024)
Acute kidney injury (AKI) and chronic kidney disease (CKD) are major health concerns due to their increasing incidence and high mortality. They are interconnected syndromes; AKI without recovery evolves into acute kidney disease (AKD), which can indi
Externí odkaz:
https://doaj.org/article/96ba26bb60574742a2ef773f4dfa8e7a
Autor:
Jérôme Jeanblanc, Pierre Sauton, Charles Houdant, Sandra Fernandez Rodriguez, Sofia Vilelas de Sousa, Virginie Jeanblanc, Sandra Bodeau, Laurence Labat, Marion Soichot, Florence Vorspan, Mickael Naassila
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Clinical studies on the effectiveness of Baclofen in alcohol use disorder (AUD) yielded mixed results possibly because of differential effects of the enantiomers and sex-related differences. Here we examined the effect of the different
Externí odkaz:
https://doaj.org/article/1ee480dfcf4e42909cb61bc7b687cc6c
Autor:
Pauline Caillard, Youssef Bennis, Isabelle Six, Sandra Bodeau, Saïd Kamel, Gabriel Choukroun, Julien Maizel, Dimitri Titeca-Beauport
Publikováno v:
Toxins, Vol 14, Iss 5, p 336 (2022)
Acute kidney injury (AKI) is a frequent disease encountered in the hospital, with a higher incidence in intensive care units. Despite progress in renal replacement therapy, AKI is still associated with early and late complications, especially cardiov
Externí odkaz:
https://doaj.org/article/304fe81d4e6048ce82ee476dc2f60b44
Autor:
Camille André, Touria Mernissi, Gabriel Choukroun, Youssef Bennis, Saïd Kamel, Sophie Liabeuf, Sandra Bodeau
Publikováno v:
Toxins, Vol 14, Iss 1, p 15 (2021)
The renal elimination of uremic toxins (UTs) can be potentially altered by drugs that inhibit organic anion transporters 1/3 (OAT1/OAT3). The objective of the present study was to determine whether the prescription of at least one OAT1/OAT3 inhibitor
Externí odkaz:
https://doaj.org/article/07bbfd9e515746fbb5389b6cf1ea5c35
Autor:
Benjamin Batteux, Sandra Bodeau, Camille André, Anne-Sophie Hurtel-Lemaire, Valérie Gras-Champel, Isabelle Desailly-Henry, Kamel Masmoudi, Youssef Bennis, Ziad A. Massy, Saïd Kamel, Gabriel Choukroun, Sophie Liabeuf
Publikováno v:
Toxins, Vol 12, Iss 11, p 715 (2020)
Although uremic osteoporosis is a component of mineral and bone disorder in chronic kidney disease, uremic toxin (UT) concentrations in patients with end-stage kidney disease and bone mineral density (BMD) changes after kidney transplantation have no
Externí odkaz:
https://doaj.org/article/62959a0dab984bd09b01d28ba904560e
Autor:
Youssef Bennis, Yan Cluet, Dimitri Titeca-Beauport, Najeh El Esper, Pablo Ureña, Sandra Bodeau, Christian Combe, Bertrand Dussol, Denis Fouque, Gabriel Choukroun, Sophie Liabeuf
Publikováno v:
Toxins, Vol 11, Iss 5, p 279 (2019)
High serum levels of gut-derived uremic toxins, especially p-cresyl sulfate (pCS), indoxyl sulfate (IS) and indole acetic acid (IAA), have been linked to adverse outcomes in patients with chronic kidney disease (CKD). Sevelamer carbonate could repres
Externí odkaz:
https://doaj.org/article/4790423124b8492190b57318e3cbd841
Autor:
Aurélie Lenglet, Sophie Liabeuf, Sandra Bodeau, Loïc Louvet, Aurélien Mary, Agnès Boullier, Anne Sophie Lemaire-Hurtel, Alexia Jonet, Pascal Sonnet, Said Kamel, Ziad A. Massy
Publikováno v:
Toxins, Vol 8, Iss 11, p 339 (2016)
N-methyl-2-pyridone-5-carboxamide (2PY, a major metabolite of nicotinamide, NAM) was recently identified as a uremic toxin. Recent interventional trials using NAM to treat high levels of phosphorus in end-stage renal disease have highlighted new pote
Externí odkaz:
https://doaj.org/article/66d268a591eb4972bfeb703207495259
Autor:
Pauline Griffeuille, Souleiman El Balkhi, Sandra Bodeau, Fabien Lamoureux, Pierre Marquet, Sylvain Dulaurent, Franck Saint-Marcoux
Publikováno v:
Journal of Analytical Toxicology. 47:89-95
Metformin (MtF) is a treatment used for type 2 diabetes. Lactic acidosis (LA) is a frequent complication that can be either induced by or associated with elevated MtF plasma concentrations. When coupled with a mass spectrometry (MS) system, the probe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eefd2ea6afc3e32235d80a4791691cd6
https://doi.org/10.1093/jat/bkac034
https://doi.org/10.1093/jat/bkac034
Autor:
Touria Mernissi, Camille André, Anaïs Périn, Chloé Thézée, Claudie Talandier, Kamel Masmoudi, Marie-Charlotte Quinton-Bouvier, Youssef Bennis, Sandra Bodeau, Anne-Sophie Lemaire-Hurtel
Publikováno v:
Toxicologie Analytique et Clinique. 34:86-93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac4ad48514b49d4f37c62eba4a5a29e1
https://doi.org/10.1016/j.toxac.2021.12.005
https://doi.org/10.1016/j.toxac.2021.12.005
Autor:
Camille André, Touria Mernissi, Bénédicte Duvauchelle, Youssef Bennis, Marie-Charlotte Quinton-Bouvier, Kamel Masmoudi, Sandra Bodeau, Anthony Quero, Roland Molinié, Gilles Mairesse, Solène Bassard, Cécile Manaouil, Anne-Sophie Lemaire-Hurtel
Publikováno v:
Toxicologie Analytique et Clinique.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b334fee601e782b38b2299d506eec23
https://doi.org/10.1016/j.toxac.2022.12.003
https://doi.org/10.1016/j.toxac.2022.12.003